Term
|
Definition
s/s - sense of breathlessness, tightness in chest, w/ wheezing, dyspnea (shortness of breath) & cough
sometimes caused by allergies. In most cases don't know cause
|
|
|
Term
chronic inflammatory airway d/o |
|
Definition
cause immune mediated airway inflammation |
|
|
Term
|
Definition
resulting in spasms & activation of inflammatory cells w/ airway inflammation & edema, excessive mucus secrections & plugging, smooth muscle atrophy, all resulting in obstruction of airflow
in addition inflammation causes bronchial hyper reactivity to mild triggers (cold air, exercise, smoke) |
|
|
Term
metered-dose inhalers (MDI's) |
|
Definition
1 to 2 puffs, 1 minute between puffs
start inhaling before activation
delivers 10% to lungs; if spacer is used - 20% delivered |
|
|
Term
|
Definition
CFC - off market by 12/2013 due to ozone damage
HFA - hydrofluralkanes |
|
|
Term
dry-powder inhalers (DPI's) |
|
Definition
breath-activated
delivers 20% to lungs more than MDI alone |
|
|
Term
nebulizer (SVN - small volume nebulizer) |
|
Definition
creates a mist
delivered by face mask or mouth piece
several minutes to deliver a 1 puff MDI equivalent |
|
|
Term
budesonide (Pulmicort)
fluticasone propionate (Flovent)
prophylaxis anti-inflammatory (long term tx):
"inhaled glucocorticoid"
suppresses inflammation, reducing bronchial hyperreactivity; ↓ airway mucus production; ↑ # of bronchial beta2 receptors & their responsiveness to beta2 agonist |
|
Definition
Route: inhaled
Use: prophylaxis of chronic asthma (fixed schedule(daily, BID, etc), not PRN)
Effect: ↓ intensity & frequency of asthma attacks
AE: oropharyngeal candidiasis (thrush), dysphonia (horse voice)(lessened w/ use of spacer); slow growth in children & adolescents; prolonged therapy - risk of bone loss, cataracts & glaucoma
|
|
|
Term
prednisone
prednisolone
prophylaxis anti-inflammatory (long term tx):
"oral glucocorticoid"
similar in action to inhaled glucocorticoids |
|
Definition
Route: PO
Use: prophylaxis of asthma
Effect: ↓ intensity & frequency of asthma attacks
AE: adrenal suppression; osteoporosis; hyperglycemia; peptic ulcer disease (PUD); suppression of growth (youth) |
|
|
Term
zileuton (Zyflo)
prophylaxis anti-inflammatory (long term tx):
"leukotriene modifier"
inhibits leukotriene synthesis (leukotrienes promote bronchoconstriction, mucus production & airway edema) |
|
Definition
Route: PO
Use: prophylaxis & maintenence therapy for asthma
Effect: ↓ bronchoconstriction, inflammation, mucus & edema
AE: hepatotoxicity to symptomatic hepatitis (reversible) - monitor LFT's (liver function tests); neuropsychiatric effects (depression, anxiety, agitation, abnormal dreams, hallucinations, insomnia, irritiability, restlessness, SI (suicidal ideation))
DD: ↑ theophylline levels; ↑ warfarin levels; ↑ propranolol levels (↓ BP, ↓ HR)
|
|
|
Term
zafirlukast (Accolate)
prophylaxis anti-inflammatory (long term tx):
"leukotriene modifier"
leukotriene antagonist |
|
Definition
Route: PO (1 hr AC or 2 hr PC)
Use: maintenance therapy for chronic asthma
Effect: reduced filtration of inflammatory cells; ↓ bronchoconstriction
AE: rare - liver injury; common - HA; GI disturbance & some incidence of neuropsych s/s - both infrequent
DD: ↑ theophylline & warfarin levels
|
|
|
Term
montelukast (Singulair)
prophylaxis anti-inflammatory (long term tx):
"leukotriene modifier"
leukotriene antagonist |
|
Definition
Route: PO
Use: maintenance therapy for asthma, use in exercise induced asthma
Effect: ↓ asthma-related nocturnal awakening (take at HS); ↑ morning lung function; ↓ need for inhaled beta2 agonists
AE: no hepatotoxicity
DD: none noted at this time
|
|
|
Term
cromolyn (Intal)
prophylaxis anti-inflammatory (long term tx):
"mast cell stabilizer"
prevents histamine release from mast cells, ↓ inflammation |
|
Definition
Route: MDI; nebulizer
Use: prophylaxis for moderate asthma; ineffective for ongoing attack; use prior to allergen exposure; exercise-induced bronchospasm; allergic rhinitis (inflammation of the nasal passage)
Effects: ↓ frequency/intensity of asthma attacks
AE: safest antiasthmatic
|
|
|
Term
omalizumab (Xoliar)
prophylaxis anti-inflammatory (long term tx):
"monoclonal antibody"
antagonizes IgE; limits the ability of allergens to release histamine |
|
Definition
Route: SC
Use: second line agent for allergy related asthma; last resort
AE: injection site irritation (45%), viral infections (23%), URI(upper respiratory infection)(20%), sinusitis (inflammation of the sinus), HA, pharyngitis (inflammation of the pharynx); also a risk for anaphylaxis, cancer
used in pts > 12 yrs of age |
|
|
Term
albuterol (Proventil), levalbuterol (Xopenex), pirbuterol (Maxair)
acute attack tx bronchodilators (short term tx):
"beta2-adrenergic agonist"
short acting beta agonist (SABA) |
|
Definition
Route: inhaled (immediate onset, 30-60 min peak)
Action: simpathomimetic (stimulates resp); stimulates beta2 receptors in smooth muscle (bronchodilation); suppresses histamine release; ↑ ciliary motility
Use: quick relief of ongoing asthma attack & long term control; used prior to exercise as prophylaxis
Effect: bronchodilation, relieves bronchospasm
AE: systemic effects (tacycardia, angina, tremor), aggravated in excessive dosages
|
|
|
Term
formoterol (Fordil), arformoterol (Brovana)
acute attack tx bronchodilators (short term tx):
"beta2-adrenergic agonist"
long acting beta agonist (LABA) |
|
Definition
Route: PO
Action: simpathomimetic (stimulates resp); stimulates beta2 receptors in smooth muscle (bronchodilation); suppresses histamine release; ↑ ciliary motility
Use: quick relief of ongoing asthma attack & long term control; used prior to exercise as prophylaxis
Effect: bronchodilation, relieves bronchospasm
AE: tremors, may activate beta1 receptors in heart; angina, tachy dysrhythmia |
|
|
Term
theophylline (Theo-24)
"methylxanthine"
bronchodilation by relaxing bronchi smooth muscle |
|
Definition
Route: PO (used for chronic asthma), IV (acute attack)
Use: maintenance therapy of chronic stable asthma
Effect: ↓ intensity & frequency of asthma attacks; appropriate for nocturnal attacks r/t prolonged effects when used regularly
AE: at 20-25 mcg/mL - GI (N, V, diarrhea); insomnia; restlessness
Toxcity: above 30 mcg/mL - severe dysrhythmias (v. fib), convulsions; death from cardiorespiratory collapse.
DD: caffeine - intensifies AE of theophylline; cimetidine (Tagamet), fluoroquinolone antibiotics - ↑ levels of theophylline; phenobarbital, phenytoin, rifampin - ↓ levels of theophylline
|
|
|
Term
aminophylline
"methylxanthine" |
|
Definition
theophylline salt; more soluable than theophylline - in solution, becomes theophylline
1 aminophylline = 2 theophylline (dose differently)
monitor frequently; therapeutic reange 10-20 mcg/mL |
|
|
Term
ipratropium (Atrovent) - short acting
tiotropium (Spiriva) - long acting
anticholinergic:
"atropine derivative"
bronchodilator, relieves bronchospasm in COPD; used in asthma |
|
Definition
Route: MDI (Atrovent) - onset 30 seconds; spinhaler (Spiriva)
Use: allergen-induced asthma; exercise-induced bronchospasm (less effective than beta2 agonist, additive effect w/ beta2 agonist)
Effect: bronchodilation
AE: dry mouth, irritation of pharnyx; raise intraocular pressure in glaucoma pts
|
|
|
Term
fluticasone/salmeterol (Advair)
"glucocorticoid/LABA combination"
anti-inflammatory and bronchodilation |
|
Definition
Use: long term maintenance - reserved for pts not adequatly controlled w/ inhaled glucocorticoid, not initial therapy
fixed dose combinations
AE: none |
|
|
Term
|
Definition
inflammatory d/o of the upper airway, lower airway and eyes
s/s: sneezing, rhinorrhea (runny nose), conjuctivitis, sinusitis, asthma; secondary to histamine, leukotriene & prostagliandin release (response to allergies)
hay fever; perennial rhinitis (indoor allergens) |
|
|
Term
beclomethasone (Beconade)
"intranasal glucocorticoid"
anti-inflammatory |
|
Definition
Route: intranasal
Use: seasonal & perennial rhinitis
Effect: suppresses major s/s of allergic rhinitis - congestion, rhinorrhea, sneezing, nasal pruritis & erythema
AE: drying of nasal mucoas; sensation of burning or itching (r/t vehicle), sore throat, epistaxis (severe nose bleed), HA |
|
|
Term
diphenhydramine (Benadryl)
"antihistamine"
histamine receptor antagonist |
|
Definition
Route: PO
Use: prophylaxis for allergic rhinitis & allergic reaction
Effect: relieve sneezing, rhinorrhea, nasal pruritis; no ↓ in nasal congestion
AE: sedation, anticholinergic effects (dry mouth, C , urinary hesitancy) |
|
|
Term
cromolyn sodium (NasalCrom)
"intranasal mast cell stabilizer"
suppressess histamine release from mast cells |
|
Definition
Route: intranasal
Use: prophylaxis - prevent allergic rhinitis
Effect: relieve s/s of allergic rhinitis
AE: minimal |
|
|
Term
phenylephrine (Neo-synephrine), pseudo ephedrine (Sudafed)
"decongestant (sympathomimetic)"
stimulates alpha-adrenergic receptors on nasal blood vessels, causes vasoconstriction shrinking swollen membranes
|
|
Definition
Route: intranasal drops/spray, PO (Sudafed)
Use: only relieves stuffiness in allergic rhinitis, no other symptom relief
Effect: reduce congestion
AE: intranasal (rebound congestion - limit to 3-5 days use); oral (CNS stimulation - restlessness, irritability, anxiety, insomnia; CV effects - vasoconstriction (hazardous in pts w/ HTN or CAD); abuse potential r/t CNS stimulation
|
|
|
Term
montelukast (Singulair)
leukotriene antagonist |
|
Definition
Route: PO
Use: seasonal & perennial allergic rhinitis
Effect: ↓ nasal congestion
AE: rare - neuropsychiatric (agitation, aggression, hallucination, depression, insomnia, restlessness, SI
last drug of choice due to AEs |
|
|
Term
codiene (Paveral), hydrocodone (Hycodan)
"opioid antitussive(cough)"
CNS elevation of cough threshold |
|
Definition
Route: PO (doses are about 1/10 of those used in pain relief)
Use: cough suppressant
Effect: reduce frequency & intensity of cough
AE: respiratory suppression (do not use w/ nocturnal apnea); abuse potential (Schedule II - codeine alone; Schedule V for codeine in antitussive mixtures)
|
|
|
Term
dextromethorphan (Drixoral, Pertussin, Robitussin DM)
"nonopioid antitussive"
raise cough threshold in CNS |
|
Definition
Route: PO
Use: cough suppressant
Effect: reduce frequency & intensity of cough; enhance analgesic effects of opioids (doubles morphine's analgesia)
AE: minimal (no euphoria or dependence; no resp depression)
|
|
|
Term
benzonatate (Tessalon)
"nonopioid antitussive"
derivative of tetracaine & procaine; ↓ sensitivity of resp tract stretch receptors |
|
Definition
Route: PO capsules (cannot be opened or crushed)
Use: cough suppressant
Effect: reduce frequency & intensity of cough
AE: mild sedation, dizziness; C
|
|
|
Term
|
Definition
agent that stimulates the flow of respiratory secretions to yield a "productive" cough
guaifenesin (Musinex, Humbid) |
|
|
Term
|
Definition
acts directly w/ mucus to make it "watery" and make cough more productive
acetylcysteine (Mucomyst) - nebulizer; hypertonic saline (3%)
caution: both mucolytics can cause bronchospasm |
|
|